Acting on sex and gender in medical innovation is good for business.
Vijayasingham L., Bischof E., Ateghang-Awankem B., Rumaney M., Otmani Del Barrio M., Cheah PY., Ter-Meulen AS., Tannenbaum C., Morgan R., Wolfe J., Gender and Covid-19 Research Agenda Setting Initiative None.
Lavanya Vijayasingham and colleagues argue that as well as improving safety and efficacy, considering sex and gender related factors in medical research can have commercial benefits